Bioxytran, Inc. (OTCMKTS:BIXT) Sees Large Increase in Short Interest

Bioxytran, Inc. (OTCMKTS:BIXT) was the target of a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 77,600 shares, an increase of 254.3% from the November 30th total of 21,900 shares. Based on an average daily trading volume, of 83,100 shares, the short-interest ratio is currently 0.9 days.

Bioxytran Price Performance

OTCMKTS:BIXT traded up $0.01 during mid-day trading on Friday, reaching $0.09. The company’s stock had a trading volume of 2,790 shares, compared to its average volume of 82,571. Bioxytran has a twelve month low of $0.08 and a twelve month high of $0.17. The company’s fifty day simple moving average is $0.09 and its two-hundred day simple moving average is $0.10. The stock has a market cap of $8.16 million, a P/E ratio of -9.40 and a beta of -0.80.

About Bioxytran

Bioxytran, Inc, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company’s lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing.